Global Oncolytic Adenovirus Market Research Report 2026(Status and Outlook)
Oncolytic adenovirus is a type of adenovirus that has been genetically engineered to selectively replicate within tumor cells and cause cell lysis, while also stimulating the body's immune system to fight against tumors. This type of virus originates from adenovirus that exists in nature and usually has low pathogenicity to the human body. After modification, it has acquired the ability to specifically target and kill tumor cells. According to the degree of genetic modification, it can be divided into two categories: conditional replication type and armed type. The former involves deleting or mutating genes related to normal cell replication in the viral genome, allowing it to only replicate effectively in tumor cells, while the latter carries additional therapeutic genes (such as cytokines, tumor suppressor genes, etc.) while retaining its oncolytic ability, further enhancing its anti-tumor effect.The global oncolytic adenovirus market has shown a rapid growth trend in recent years. The global burden of cancer continues to increase, creating a huge unmet medical need. Traditional cancer treatment methods, such as chemotherapy and radiotherapy, have significant limitations, which have driven the development of innovative therapies such as oncolytic viruses. The advancement of biotechnology has reduced the research and production costs of oncolytic adenovirus, and the favor of the capital market has provided sufficient financial support for the industry. North America currently dominates the global market, followed closely by Europe. Although the Asia Pacific region (especially China) started relatively late, it has enormous growth potential. At present, oncolytic adenovirus is mainly used for the treatment of solid tumors, and its indications are showing a diversified trend. The market competition is fierce, and multinational companies such as Merck, Roche, and Amgen rely on their strong research and development capabilities, financial support, and extensive market channels to continuously launch new products and expand market share through mergers and acquisitions, cooperation, and other means. Meanwhile, emerging biotechnology companies such as Viralytics are gradually emerging, focusing on the research and innovation of oncolytic adenovirus. Through technological innovation and clinical trials, they develop products with differentiated advantages. From a technological perspective, the competition in the field of oncolytic adenovirus mainly focuses on vector optimization, arming strategies, and combination therapies. Vector optimization technology is currently the core direction of oncolytic adenovirus research and development. Armed oncolytic adenovirus represents one of the most promising technological routes, and combination therapy strategies have become the mainstream paradigm for clinical development of oncolytic adenovirus. In addition, innovative drug delivery routes are a key link in improving the efficacy of oncolytic adenovirus, and optimizing production processes is a necessary path for oncolytic adenovirus to move from the laboratory to the market. In the future, oncolytic adenovirus technology will develop towards intelligence and multifunctionality. The next generation of oncolytic adenovirus may have environmental responsiveness, autonomously regulating replication intensity based on tumor microenvironment signals, or designed as a "modular platform" that allows for flexible loading of therapeutic gene combinations according to different tumor types. In addition, the cross-border integration of oncolytic adenovirus with emerging technologies such as nanomaterials and electric field therapy will also create new therapeutic possibilities.
The global Oncolytic Adenovirus market size was estimated at USD 1500.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 17.60% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Oncolytic Adenovirus market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Oncolytic Adenovirus market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Oncolytic Adenovirus market.
Global Oncolytic Adenovirus Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Merck
Roche
Transgene
Agenus
Oncorus
Viralytics
Amgen
Targovax
Sorrento Therapeutics
Shanghai Pharma Sunway Biotech
Jiangsu Hengrui Pharmaceuticals
Fosun Pharma
BeiGene
Junshi Biosciences
Chengdu Kanghua Biological Products
3SBio
Changchun High & New Technology Industries
Market Segmentation (by Type)
Conditional Replication Adenovirus
Armed Oncolytic Adenovirus
Market Segmentation (by Application)
Head And Neck Cancer
Liver Cancer
Colorectal Cancer
Prostate Cancer
Ovarian Cancer
Non-Small Cell Lung Cancer
Glioblastoma
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Oncolytic Adenovirus Market
Overview of the regional outlook of the Oncolytic Adenovirus Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Oncolytic Adenovirus Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Oncolytic Adenovirus, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Oncolytic Adenovirus market size was estimated at USD 1500.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 17.60% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Oncolytic Adenovirus market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Oncolytic Adenovirus market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Oncolytic Adenovirus market.
Global Oncolytic Adenovirus Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Merck
Roche
Transgene
Agenus
Oncorus
Viralytics
Amgen
Targovax
Sorrento Therapeutics
Shanghai Pharma Sunway Biotech
Jiangsu Hengrui Pharmaceuticals
Fosun Pharma
BeiGene
Junshi Biosciences
Chengdu Kanghua Biological Products
3SBio
Changchun High & New Technology Industries
Market Segmentation (by Type)
Conditional Replication Adenovirus
Armed Oncolytic Adenovirus
Market Segmentation (by Application)
Head And Neck Cancer
Liver Cancer
Colorectal Cancer
Prostate Cancer
Ovarian Cancer
Non-Small Cell Lung Cancer
Glioblastoma
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Oncolytic Adenovirus Market
Overview of the regional outlook of the Oncolytic Adenovirus Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Oncolytic Adenovirus Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Oncolytic Adenovirus, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Oncolytic Adenovirus
1.2 Key Market Segments
1.2.1 Oncolytic Adenovirus Segment by Type
1.2.2 Oncolytic Adenovirus Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ONCOLYTIC ADENOVIRUS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Oncolytic Adenovirus Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Oncolytic Adenovirus Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ONCOLYTIC ADENOVIRUS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Oncolytic Adenovirus Product Life Cycle
3.3 Global Oncolytic Adenovirus Sales by Manufacturers (2020-2025)
3.4 Global Oncolytic Adenovirus Revenue Market Share by Manufacturers (2020-2025)
3.5 Oncolytic Adenovirus Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Oncolytic Adenovirus Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Oncolytic Adenovirus Market Competitive Situation and Trends
3.8.1 Oncolytic Adenovirus Market Concentration Rate
3.8.2 Global 5 and 10 Largest Oncolytic Adenovirus Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 ONCOLYTIC ADENOVIRUS INDUSTRY CHAIN ANALYSIS
4.1 Oncolytic Adenovirus Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF ONCOLYTIC ADENOVIRUS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Oncolytic Adenovirus Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Oncolytic Adenovirus Market
5.7 ESG Ratings of Leading Companies
6 ONCOLYTIC ADENOVIRUS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Oncolytic Adenovirus Sales Market Share by Type (2020-2025)
6.3 Global Oncolytic Adenovirus Market Size by Type (2020-2025)
6.4 Global Oncolytic Adenovirus Price by Type (2020-2025)
7 ONCOLYTIC ADENOVIRUS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Oncolytic Adenovirus Market Sales by Application (2020-2025)
7.3 Global Oncolytic Adenovirus Market Size (M USD) by Application (2020-2025)
7.4 Global Oncolytic Adenovirus Sales Growth Rate by Application (2020-2025)
8 ONCOLYTIC ADENOVIRUS MARKET SALES BY REGION
8.1 Global Oncolytic Adenovirus Sales by Region
8.1.1 Global Oncolytic Adenovirus Sales by Region
8.1.2 Global Oncolytic Adenovirus Sales Market Share by Region
8.2 Global Oncolytic Adenovirus Market Size by Region
8.2.1 Global Oncolytic Adenovirus Market Size by Region
8.2.2 Global Oncolytic Adenovirus Market Size by Region
8.3 North America
8.3.1 North America Oncolytic Adenovirus Sales by Country
8.3.2 North America Oncolytic Adenovirus Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Oncolytic Adenovirus Sales by Country
8.4.2 Europe Oncolytic Adenovirus Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Oncolytic Adenovirus Sales by Region
8.5.2 Asia Pacific Oncolytic Adenovirus Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Oncolytic Adenovirus Sales by Country
8.6.2 South America Oncolytic Adenovirus Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Oncolytic Adenovirus Sales by Region
8.7.2 Middle East and Africa Oncolytic Adenovirus Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 ONCOLYTIC ADENOVIRUS MARKET PRODUCTION BY REGION
9.1 Global Production of Oncolytic Adenovirus by Region(2020-2025)
9.2 Global Oncolytic Adenovirus Revenue Market Share by Region (2020-2025)
9.3 Global Oncolytic Adenovirus Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Oncolytic Adenovirus Production
9.4.1 North America Oncolytic Adenovirus Production Growth Rate (2020-2025)
9.4.2 North America Oncolytic Adenovirus Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Oncolytic Adenovirus Production
9.5.1 Europe Oncolytic Adenovirus Production Growth Rate (2020-2025)
9.5.2 Europe Oncolytic Adenovirus Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Oncolytic Adenovirus Production (2020-2025)
9.6.1 Japan Oncolytic Adenovirus Production Growth Rate (2020-2025)
9.6.2 Japan Oncolytic Adenovirus Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Oncolytic Adenovirus Production (2020-2025)
9.7.1 China Oncolytic Adenovirus Production Growth Rate (2020-2025)
9.7.2 China Oncolytic Adenovirus Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Merck
10.1.1 Merck Basic Information
10.1.2 Merck Oncolytic Adenovirus Product Overview
10.1.3 Merck Oncolytic Adenovirus Product Market Performance
10.1.4 Merck Business Overview
10.1.5 Merck SWOT Analysis
10.1.6 Merck Recent Developments
10.2 Roche
10.2.1 Roche Basic Information
10.2.2 Roche Oncolytic Adenovirus Product Overview
10.2.3 Roche Oncolytic Adenovirus Product Market Performance
10.2.4 Roche Business Overview
10.2.5 Roche SWOT Analysis
10.2.6 Roche Recent Developments
10.3 Transgene
10.3.1 Transgene Basic Information
10.3.2 Transgene Oncolytic Adenovirus Product Overview
10.3.3 Transgene Oncolytic Adenovirus Product Market Performance
10.3.4 Transgene Business Overview
10.3.5 Transgene SWOT Analysis
10.3.6 Transgene Recent Developments
10.4 Agenus
10.4.1 Agenus Basic Information
10.4.2 Agenus Oncolytic Adenovirus Product Overview
10.4.3 Agenus Oncolytic Adenovirus Product Market Performance
10.4.4 Agenus Business Overview
10.4.5 Agenus Recent Developments
10.5 Oncorus
10.5.1 Oncorus Basic Information
10.5.2 Oncorus Oncolytic Adenovirus Product Overview
10.5.3 Oncorus Oncolytic Adenovirus Product Market Performance
10.5.4 Oncorus Business Overview
10.5.5 Oncorus Recent Developments
10.6 Viralytics
10.6.1 Viralytics Basic Information
10.6.2 Viralytics Oncolytic Adenovirus Product Overview
10.6.3 Viralytics Oncolytic Adenovirus Product Market Performance
10.6.4 Viralytics Business Overview
10.6.5 Viralytics Recent Developments
10.7 Amgen
10.7.1 Amgen Basic Information
10.7.2 Amgen Oncolytic Adenovirus Product Overview
10.7.3 Amgen Oncolytic Adenovirus Product Market Performance
10.7.4 Amgen Business Overview
10.7.5 Amgen Recent Developments
10.8 Targovax
10.8.1 Targovax Basic Information
10.8.2 Targovax Oncolytic Adenovirus Product Overview
10.8.3 Targovax Oncolytic Adenovirus Product Market Performance
10.8.4 Targovax Business Overview
10.8.5 Targovax Recent Developments
10.9 Sorrento Therapeutics
10.9.1 Sorrento Therapeutics Basic Information
10.9.2 Sorrento Therapeutics Oncolytic Adenovirus Product Overview
10.9.3 Sorrento Therapeutics Oncolytic Adenovirus Product Market Performance
10.9.4 Sorrento Therapeutics Business Overview
10.9.5 Sorrento Therapeutics Recent Developments
10.10 Shanghai Pharma Sunway Biotech
10.10.1 Shanghai Pharma Sunway Biotech Basic Information
10.10.2 Shanghai Pharma Sunway Biotech Oncolytic Adenovirus Product Overview
10.10.3 Shanghai Pharma Sunway Biotech Oncolytic Adenovirus Product Market Performance
10.10.4 Shanghai Pharma Sunway Biotech Business Overview
10.10.5 Shanghai Pharma Sunway Biotech Recent Developments
10.11 Jiangsu Hengrui Pharmaceuticals
10.11.1 Jiangsu Hengrui Pharmaceuticals Basic Information
10.11.2 Jiangsu Hengrui Pharmaceuticals Oncolytic Adenovirus Product Overview
10.11.3 Jiangsu Hengrui Pharmaceuticals Oncolytic Adenovirus Product Market Performance
10.11.4 Jiangsu Hengrui Pharmaceuticals Business Overview
10.11.5 Jiangsu Hengrui Pharmaceuticals Recent Developments
10.12 Fosun Pharma
10.12.1 Fosun Pharma Basic Information
10.12.2 Fosun Pharma Oncolytic Adenovirus Product Overview
10.12.3 Fosun Pharma Oncolytic Adenovirus Product Market Performance
10.12.4 Fosun Pharma Business Overview
10.12.5 Fosun Pharma Recent Developments
10.13 BeiGene
10.13.1 BeiGene Basic Information
10.13.2 BeiGene Oncolytic Adenovirus Product Overview
10.13.3 BeiGene Oncolytic Adenovirus Product Market Performance
10.13.4 BeiGene Business Overview
10.13.5 BeiGene Recent Developments
10.14 Junshi Biosciences
10.14.1 Junshi Biosciences Basic Information
10.14.2 Junshi Biosciences Oncolytic Adenovirus Product Overview
10.14.3 Junshi Biosciences Oncolytic Adenovirus Product Market Performance
10.14.4 Junshi Biosciences Business Overview
10.14.5 Junshi Biosciences Recent Developments
10.15 Chengdu Kanghua Biological Products
10.15.1 Chengdu Kanghua Biological Products Basic Information
10.15.2 Chengdu Kanghua Biological Products Oncolytic Adenovirus Product Overview
10.15.3 Chengdu Kanghua Biological Products Oncolytic Adenovirus Product Market Performance
10.15.4 Chengdu Kanghua Biological Products Business Overview
10.15.5 Chengdu Kanghua Biological Products Recent Developments
10.16 3SBio
10.16.1 3SBio Basic Information
10.16.2 3SBio Oncolytic Adenovirus Product Overview
10.16.3 3SBio Oncolytic Adenovirus Product Market Performance
10.16.4 3SBio Business Overview
10.16.5 3SBio Recent Developments
10.17 Changchun High and New Technology Industries
10.17.1 Changchun High and New Technology Industries Basic Information
10.17.2 Changchun High and New Technology Industries Oncolytic Adenovirus Product Overview
10.17.3 Changchun High and New Technology Industries Oncolytic Adenovirus Product Market Performance
10.17.4 Changchun High and New Technology Industries Business Overview
10.17.5 Changchun High and New Technology Industries Recent Developments
11 ONCOLYTIC ADENOVIRUS MARKET FORECAST BY REGION
11.1 Global Oncolytic Adenovirus Market Size Forecast
11.2 Global Oncolytic Adenovirus Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Oncolytic Adenovirus Market Size Forecast by Country
11.2.3 Asia Pacific Oncolytic Adenovirus Market Size Forecast by Region
11.2.4 South America Oncolytic Adenovirus Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Oncolytic Adenovirus by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Oncolytic Adenovirus Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Oncolytic Adenovirus by Type (2026-2035)
12.1.2 Global Oncolytic Adenovirus Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Oncolytic Adenovirus by Type (2026-2035)
12.2 Global Oncolytic Adenovirus Market Forecast by Application (2026-2035)
12.2.1 Global Oncolytic Adenovirus Sales (K MT) Forecast by Application
12.2.2 Global Oncolytic Adenovirus Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Oncolytic Adenovirus
1.2 Key Market Segments
1.2.1 Oncolytic Adenovirus Segment by Type
1.2.2 Oncolytic Adenovirus Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ONCOLYTIC ADENOVIRUS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Oncolytic Adenovirus Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Oncolytic Adenovirus Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ONCOLYTIC ADENOVIRUS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Oncolytic Adenovirus Product Life Cycle
3.3 Global Oncolytic Adenovirus Sales by Manufacturers (2020-2025)
3.4 Global Oncolytic Adenovirus Revenue Market Share by Manufacturers (2020-2025)
3.5 Oncolytic Adenovirus Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Oncolytic Adenovirus Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Oncolytic Adenovirus Market Competitive Situation and Trends
3.8.1 Oncolytic Adenovirus Market Concentration Rate
3.8.2 Global 5 and 10 Largest Oncolytic Adenovirus Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 ONCOLYTIC ADENOVIRUS INDUSTRY CHAIN ANALYSIS
4.1 Oncolytic Adenovirus Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF ONCOLYTIC ADENOVIRUS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Oncolytic Adenovirus Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Oncolytic Adenovirus Market
5.7 ESG Ratings of Leading Companies
6 ONCOLYTIC ADENOVIRUS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Oncolytic Adenovirus Sales Market Share by Type (2020-2025)
6.3 Global Oncolytic Adenovirus Market Size by Type (2020-2025)
6.4 Global Oncolytic Adenovirus Price by Type (2020-2025)
7 ONCOLYTIC ADENOVIRUS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Oncolytic Adenovirus Market Sales by Application (2020-2025)
7.3 Global Oncolytic Adenovirus Market Size (M USD) by Application (2020-2025)
7.4 Global Oncolytic Adenovirus Sales Growth Rate by Application (2020-2025)
8 ONCOLYTIC ADENOVIRUS MARKET SALES BY REGION
8.1 Global Oncolytic Adenovirus Sales by Region
8.1.1 Global Oncolytic Adenovirus Sales by Region
8.1.2 Global Oncolytic Adenovirus Sales Market Share by Region
8.2 Global Oncolytic Adenovirus Market Size by Region
8.2.1 Global Oncolytic Adenovirus Market Size by Region
8.2.2 Global Oncolytic Adenovirus Market Size by Region
8.3 North America
8.3.1 North America Oncolytic Adenovirus Sales by Country
8.3.2 North America Oncolytic Adenovirus Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Oncolytic Adenovirus Sales by Country
8.4.2 Europe Oncolytic Adenovirus Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Oncolytic Adenovirus Sales by Region
8.5.2 Asia Pacific Oncolytic Adenovirus Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Oncolytic Adenovirus Sales by Country
8.6.2 South America Oncolytic Adenovirus Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Oncolytic Adenovirus Sales by Region
8.7.2 Middle East and Africa Oncolytic Adenovirus Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 ONCOLYTIC ADENOVIRUS MARKET PRODUCTION BY REGION
9.1 Global Production of Oncolytic Adenovirus by Region(2020-2025)
9.2 Global Oncolytic Adenovirus Revenue Market Share by Region (2020-2025)
9.3 Global Oncolytic Adenovirus Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Oncolytic Adenovirus Production
9.4.1 North America Oncolytic Adenovirus Production Growth Rate (2020-2025)
9.4.2 North America Oncolytic Adenovirus Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Oncolytic Adenovirus Production
9.5.1 Europe Oncolytic Adenovirus Production Growth Rate (2020-2025)
9.5.2 Europe Oncolytic Adenovirus Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Oncolytic Adenovirus Production (2020-2025)
9.6.1 Japan Oncolytic Adenovirus Production Growth Rate (2020-2025)
9.6.2 Japan Oncolytic Adenovirus Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Oncolytic Adenovirus Production (2020-2025)
9.7.1 China Oncolytic Adenovirus Production Growth Rate (2020-2025)
9.7.2 China Oncolytic Adenovirus Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Merck
10.1.1 Merck Basic Information
10.1.2 Merck Oncolytic Adenovirus Product Overview
10.1.3 Merck Oncolytic Adenovirus Product Market Performance
10.1.4 Merck Business Overview
10.1.5 Merck SWOT Analysis
10.1.6 Merck Recent Developments
10.2 Roche
10.2.1 Roche Basic Information
10.2.2 Roche Oncolytic Adenovirus Product Overview
10.2.3 Roche Oncolytic Adenovirus Product Market Performance
10.2.4 Roche Business Overview
10.2.5 Roche SWOT Analysis
10.2.6 Roche Recent Developments
10.3 Transgene
10.3.1 Transgene Basic Information
10.3.2 Transgene Oncolytic Adenovirus Product Overview
10.3.3 Transgene Oncolytic Adenovirus Product Market Performance
10.3.4 Transgene Business Overview
10.3.5 Transgene SWOT Analysis
10.3.6 Transgene Recent Developments
10.4 Agenus
10.4.1 Agenus Basic Information
10.4.2 Agenus Oncolytic Adenovirus Product Overview
10.4.3 Agenus Oncolytic Adenovirus Product Market Performance
10.4.4 Agenus Business Overview
10.4.5 Agenus Recent Developments
10.5 Oncorus
10.5.1 Oncorus Basic Information
10.5.2 Oncorus Oncolytic Adenovirus Product Overview
10.5.3 Oncorus Oncolytic Adenovirus Product Market Performance
10.5.4 Oncorus Business Overview
10.5.5 Oncorus Recent Developments
10.6 Viralytics
10.6.1 Viralytics Basic Information
10.6.2 Viralytics Oncolytic Adenovirus Product Overview
10.6.3 Viralytics Oncolytic Adenovirus Product Market Performance
10.6.4 Viralytics Business Overview
10.6.5 Viralytics Recent Developments
10.7 Amgen
10.7.1 Amgen Basic Information
10.7.2 Amgen Oncolytic Adenovirus Product Overview
10.7.3 Amgen Oncolytic Adenovirus Product Market Performance
10.7.4 Amgen Business Overview
10.7.5 Amgen Recent Developments
10.8 Targovax
10.8.1 Targovax Basic Information
10.8.2 Targovax Oncolytic Adenovirus Product Overview
10.8.3 Targovax Oncolytic Adenovirus Product Market Performance
10.8.4 Targovax Business Overview
10.8.5 Targovax Recent Developments
10.9 Sorrento Therapeutics
10.9.1 Sorrento Therapeutics Basic Information
10.9.2 Sorrento Therapeutics Oncolytic Adenovirus Product Overview
10.9.3 Sorrento Therapeutics Oncolytic Adenovirus Product Market Performance
10.9.4 Sorrento Therapeutics Business Overview
10.9.5 Sorrento Therapeutics Recent Developments
10.10 Shanghai Pharma Sunway Biotech
10.10.1 Shanghai Pharma Sunway Biotech Basic Information
10.10.2 Shanghai Pharma Sunway Biotech Oncolytic Adenovirus Product Overview
10.10.3 Shanghai Pharma Sunway Biotech Oncolytic Adenovirus Product Market Performance
10.10.4 Shanghai Pharma Sunway Biotech Business Overview
10.10.5 Shanghai Pharma Sunway Biotech Recent Developments
10.11 Jiangsu Hengrui Pharmaceuticals
10.11.1 Jiangsu Hengrui Pharmaceuticals Basic Information
10.11.2 Jiangsu Hengrui Pharmaceuticals Oncolytic Adenovirus Product Overview
10.11.3 Jiangsu Hengrui Pharmaceuticals Oncolytic Adenovirus Product Market Performance
10.11.4 Jiangsu Hengrui Pharmaceuticals Business Overview
10.11.5 Jiangsu Hengrui Pharmaceuticals Recent Developments
10.12 Fosun Pharma
10.12.1 Fosun Pharma Basic Information
10.12.2 Fosun Pharma Oncolytic Adenovirus Product Overview
10.12.3 Fosun Pharma Oncolytic Adenovirus Product Market Performance
10.12.4 Fosun Pharma Business Overview
10.12.5 Fosun Pharma Recent Developments
10.13 BeiGene
10.13.1 BeiGene Basic Information
10.13.2 BeiGene Oncolytic Adenovirus Product Overview
10.13.3 BeiGene Oncolytic Adenovirus Product Market Performance
10.13.4 BeiGene Business Overview
10.13.5 BeiGene Recent Developments
10.14 Junshi Biosciences
10.14.1 Junshi Biosciences Basic Information
10.14.2 Junshi Biosciences Oncolytic Adenovirus Product Overview
10.14.3 Junshi Biosciences Oncolytic Adenovirus Product Market Performance
10.14.4 Junshi Biosciences Business Overview
10.14.5 Junshi Biosciences Recent Developments
10.15 Chengdu Kanghua Biological Products
10.15.1 Chengdu Kanghua Biological Products Basic Information
10.15.2 Chengdu Kanghua Biological Products Oncolytic Adenovirus Product Overview
10.15.3 Chengdu Kanghua Biological Products Oncolytic Adenovirus Product Market Performance
10.15.4 Chengdu Kanghua Biological Products Business Overview
10.15.5 Chengdu Kanghua Biological Products Recent Developments
10.16 3SBio
10.16.1 3SBio Basic Information
10.16.2 3SBio Oncolytic Adenovirus Product Overview
10.16.3 3SBio Oncolytic Adenovirus Product Market Performance
10.16.4 3SBio Business Overview
10.16.5 3SBio Recent Developments
10.17 Changchun High and New Technology Industries
10.17.1 Changchun High and New Technology Industries Basic Information
10.17.2 Changchun High and New Technology Industries Oncolytic Adenovirus Product Overview
10.17.3 Changchun High and New Technology Industries Oncolytic Adenovirus Product Market Performance
10.17.4 Changchun High and New Technology Industries Business Overview
10.17.5 Changchun High and New Technology Industries Recent Developments
11 ONCOLYTIC ADENOVIRUS MARKET FORECAST BY REGION
11.1 Global Oncolytic Adenovirus Market Size Forecast
11.2 Global Oncolytic Adenovirus Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Oncolytic Adenovirus Market Size Forecast by Country
11.2.3 Asia Pacific Oncolytic Adenovirus Market Size Forecast by Region
11.2.4 South America Oncolytic Adenovirus Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Oncolytic Adenovirus by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Oncolytic Adenovirus Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Oncolytic Adenovirus by Type (2026-2035)
12.1.2 Global Oncolytic Adenovirus Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Oncolytic Adenovirus by Type (2026-2035)
12.2 Global Oncolytic Adenovirus Market Forecast by Application (2026-2035)
12.2.1 Global Oncolytic Adenovirus Sales (K MT) Forecast by Application
12.2.2 Global Oncolytic Adenovirus Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Oncolytic Adenovirus Market Size by Type (M USD)
Table 4. Global Oncolytic Adenovirus Market Size by Application
Table 5. Oncolytic Adenovirus Market Size Comparison by Region (M USD)
Table 6. Global Oncolytic Adenovirus Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Oncolytic Adenovirus Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Oncolytic Adenovirus Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Oncolytic Adenovirus Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncolytic Adenovirus as of 2025)
Table 11. Global Market Oncolytic Adenovirus Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Oncolytic Adenovirus Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Oncolytic Adenovirus Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Oncolytic Adenovirus Sales by Type (K MT)
Table 27. Global Oncolytic Adenovirus Market Size by Type (M USD)
Table 28. Global Oncolytic Adenovirus Sales (K MT) by Type (2020-2025)
Table 29. Global Oncolytic Adenovirus Sales Market Share by Type (2020-2025)
Table 30. Global Oncolytic Adenovirus Market Size (M USD) by Type (2020-2025)
Table 31. Global Oncolytic Adenovirus Market Share by Type (2020-2025)
Table 32. Global Oncolytic Adenovirus Price (USD/KG) by Type (2020-2025)
Table 33. Global Oncolytic Adenovirus Sales (K MT) by Application
Table 34. Global Oncolytic Adenovirus Market Size by Application
Table 35. Global Oncolytic Adenovirus Sales by Application (2020-2025) & (K MT)
Table 36. Global Oncolytic Adenovirus Sales Market Share by Application (2020-2025)
Table 37. Global Oncolytic Adenovirus Market Size by Application (2020-2025) & (M USD)
Table 38. Global Oncolytic Adenovirus Market Share by Application (2020-2025)
Table 39. Global Oncolytic Adenovirus Sales Growth Rate by Application (2020-2025)
Table 40. Global Oncolytic Adenovirus Sales by Region (2020-2025) & (K MT)
Table 41. Global Oncolytic Adenovirus Sales Market Share by Region (2020-2025)
Table 42. Global Oncolytic Adenovirus Market Size by Region (2020-2025) & (M USD)
Table 43. Global Oncolytic Adenovirus Market Size by Region (2020-2025)
Table 44. North America Oncolytic Adenovirus Sales by Country (2020-2025) & (K MT)
Table 45. North America Oncolytic Adenovirus Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Oncolytic Adenovirus Sales by Country (2020-2025) & (K MT)
Table 47. Europe Oncolytic Adenovirus Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Oncolytic Adenovirus Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Oncolytic Adenovirus Market Size by Region (2020-2025) & (M USD)
Table 50. South America Oncolytic Adenovirus Sales by Country (2020-2025) & (K MT)
Table 51. South America Oncolytic Adenovirus Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Oncolytic Adenovirus Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Oncolytic Adenovirus Market Size by Region (2020-2025) & (M USD)
Table 54. Global Oncolytic Adenovirus Production (K MT) by Region(2020-2025)
Table 55. Global Oncolytic Adenovirus Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Oncolytic Adenovirus Revenue Market Share by Region (2020-2025)
Table 57. Global Oncolytic Adenovirus Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Oncolytic Adenovirus Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Oncolytic Adenovirus Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Oncolytic Adenovirus Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Oncolytic Adenovirus Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Merck Basic Information
Table 63. Merck Oncolytic Adenovirus Product Overview
Table 64. Merck Oncolytic Adenovirus Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Merck Business Overview
Table 66. Merck SWOT Analysis
Table 67. Merck Recent Developments
Table 68. Roche Basic Information
Table 69. Roche Oncolytic Adenovirus Product Overview
Table 70. Roche Oncolytic Adenovirus Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Roche Business Overview
Table 72. Roche SWOT Analysis
Table 73. Roche Recent Developments
Table 74. Transgene Basic Information
Table 75. Transgene Oncolytic Adenovirus Product Overview
Table 76. Transgene Oncolytic Adenovirus Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Transgene Business Overview
Table 78. Transgene SWOT Analysis
Table 79. Transgene Recent Developments
Table 80. Agenus Basic Information
Table 81. Agenus Oncolytic Adenovirus Product Overview
Table 82. Agenus Oncolytic Adenovirus Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Agenus Business Overview
Table 84. Agenus Recent Developments
Table 85. Oncorus Basic Information
Table 86. Oncorus Oncolytic Adenovirus Product Overview
Table 87. Oncorus Oncolytic Adenovirus Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Oncorus Business Overview
Table 89. Oncorus Recent Developments
Table 90. Viralytics Basic Information
Table 91. Viralytics Oncolytic Adenovirus Product Overview
Table 92. Viralytics Oncolytic Adenovirus Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Viralytics Business Overview
Table 94. Viralytics Recent Developments
Table 95. Amgen Basic Information
Table 96. Amgen Oncolytic Adenovirus Product Overview
Table 97. Amgen Oncolytic Adenovirus Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Amgen Business Overview
Table 99. Amgen Recent Developments
Table 100. Targovax Basic Information
Table 101. Targovax Oncolytic Adenovirus Product Overview
Table 102. Targovax Oncolytic Adenovirus Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Targovax Business Overview
Table 104. Targovax Recent Developments
Table 105. Sorrento Therapeutics Basic Information
Table 106. Sorrento Therapeutics Oncolytic Adenovirus Product Overview
Table 107. Sorrento Therapeutics Oncolytic Adenovirus Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Sorrento Therapeutics Business Overview
Table 109. Sorrento Therapeutics Recent Developments
Table 110. Shanghai Pharma Sunway Biotech Basic Information
Table 111. Shanghai Pharma Sunway Biotech Oncolytic Adenovirus Product Overview
Table 112. Shanghai Pharma Sunway Biotech Oncolytic Adenovirus Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Shanghai Pharma Sunway Biotech Business Overview
Table 114. Shanghai Pharma Sunway Biotech Recent Developments
Table 115. Jiangsu Hengrui Pharmaceuticals Basic Information
Table 116. Jiangsu Hengrui Pharmaceuticals Oncolytic Adenovirus Product Overview
Table 117. Jiangsu Hengrui Pharmaceuticals Oncolytic Adenovirus Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Jiangsu Hengrui Pharmaceuticals Business Overview
Table 119. Jiangsu Hengrui Pharmaceuticals Recent Developments
Table 120. Fosun Pharma Basic Information
Table 121. Fosun Pharma Oncolytic Adenovirus Product Overview
Table 122. Fosun Pharma Oncolytic Adenovirus Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Fosun Pharma Business Overview
Table 124. Fosun Pharma Recent Developments
Table 125. BeiGene Basic Information
Table 126. BeiGene Oncolytic Adenovirus Product Overview
Table 127. BeiGene Oncolytic Adenovirus Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. BeiGene Business Overview
Table 129. BeiGene Recent Developments
Table 130. Junshi Biosciences Basic Information
Table 131. Junshi Biosciences Oncolytic Adenovirus Product Overview
Table 132. Junshi Biosciences Oncolytic Adenovirus Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. Junshi Biosciences Business Overview
Table 134. Junshi Biosciences Recent Developments
Table 135. Chengdu Kanghua Biological Products Basic Information
Table 136. Chengdu Kanghua Biological Products Oncolytic Adenovirus Product Overview
Table 137. Chengdu Kanghua Biological Products Oncolytic Adenovirus Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 138. Chengdu Kanghua Biological Products Business Overview
Table 139. Chengdu Kanghua Biological Products Recent Developments
Table 140. 3SBio Basic Information
Table 141. 3SBio Oncolytic Adenovirus Product Overview
Table 142. 3SBio Oncolytic Adenovirus Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 143. 3SBio Business Overview
Table 144. 3SBio Recent Developments
Table 145. Changchun High and New Technology Industries Basic Information
Table 146. Changchun High and New Technology Industries Oncolytic Adenovirus Product Overview
Table 147. Changchun High and New Technology Industries Oncolytic Adenovirus Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 148. Changchun High and New Technology Industries Business Overview
Table 149. Changchun High and New Technology Industries Recent Developments
Table 150. Global Oncolytic Adenovirus Sales Forecast by Region (2026-2035) & (K MT)
Table 151. Global Oncolytic Adenovirus Market Size Forecast by Region (2026-2035) & (M USD)
Table 152. North America Oncolytic Adenovirus Sales Forecast by Country (2026-2035) & (K MT)
Table 153. North America Oncolytic Adenovirus Market Size Forecast by Country (2026-2035) & (M USD)
Table 154. Europe Oncolytic Adenovirus Sales Forecast by Country (2026-2035) & (K MT)
Table 155. Europe Oncolytic Adenovirus Market Size Forecast by Country (2026-2035) & (M USD)
Table 156. Asia Pacific Oncolytic Adenovirus Sales Forecast by Region (2026-2035) & (K MT)
Table 157. Asia Pacific Oncolytic Adenovirus Market Size Forecast by Region (2026-2035) & (M USD)
Table 158. South America Oncolytic Adenovirus Sales Forecast by Country (2026-2035) & (K MT)
Table 159. South America Oncolytic Adenovirus Market Size Forecast by Country (2026-2035) & (M USD)
Table 160. Middle East and Africa Oncolytic Adenovirus Sales Forecast by Country (2026-2035) & (Units)
Table 161. Middle East and Africa Oncolytic Adenovirus Market Size Forecast by Country (2026-2035) & (M USD)
Table 162. Global Oncolytic Adenovirus Sales Forecast by Type (2026-2035) & (K MT)
Table 163. Global Oncolytic Adenovirus Market Size Forecast by Type (2026-2035) & (M USD)
Table 164. Global Oncolytic Adenovirus Price Forecast by Type (2026-2035) & (USD/KG)
Table 165. Global Oncolytic Adenovirus Sales (K MT) Forecast by Application (2026-2035)
Table 166. Global Oncolytic Adenovirus Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Oncolytic Adenovirus Market Size by Type (M USD)
Table 4. Global Oncolytic Adenovirus Market Size by Application
Table 5. Oncolytic Adenovirus Market Size Comparison by Region (M USD)
Table 6. Global Oncolytic Adenovirus Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Oncolytic Adenovirus Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Oncolytic Adenovirus Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Oncolytic Adenovirus Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncolytic Adenovirus as of 2025)
Table 11. Global Market Oncolytic Adenovirus Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Oncolytic Adenovirus Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Oncolytic Adenovirus Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Oncolytic Adenovirus Sales by Type (K MT)
Table 27. Global Oncolytic Adenovirus Market Size by Type (M USD)
Table 28. Global Oncolytic Adenovirus Sales (K MT) by Type (2020-2025)
Table 29. Global Oncolytic Adenovirus Sales Market Share by Type (2020-2025)
Table 30. Global Oncolytic Adenovirus Market Size (M USD) by Type (2020-2025)
Table 31. Global Oncolytic Adenovirus Market Share by Type (2020-2025)
Table 32. Global Oncolytic Adenovirus Price (USD/KG) by Type (2020-2025)
Table 33. Global Oncolytic Adenovirus Sales (K MT) by Application
Table 34. Global Oncolytic Adenovirus Market Size by Application
Table 35. Global Oncolytic Adenovirus Sales by Application (2020-2025) & (K MT)
Table 36. Global Oncolytic Adenovirus Sales Market Share by Application (2020-2025)
Table 37. Global Oncolytic Adenovirus Market Size by Application (2020-2025) & (M USD)
Table 38. Global Oncolytic Adenovirus Market Share by Application (2020-2025)
Table 39. Global Oncolytic Adenovirus Sales Growth Rate by Application (2020-2025)
Table 40. Global Oncolytic Adenovirus Sales by Region (2020-2025) & (K MT)
Table 41. Global Oncolytic Adenovirus Sales Market Share by Region (2020-2025)
Table 42. Global Oncolytic Adenovirus Market Size by Region (2020-2025) & (M USD)
Table 43. Global Oncolytic Adenovirus Market Size by Region (2020-2025)
Table 44. North America Oncolytic Adenovirus Sales by Country (2020-2025) & (K MT)
Table 45. North America Oncolytic Adenovirus Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Oncolytic Adenovirus Sales by Country (2020-2025) & (K MT)
Table 47. Europe Oncolytic Adenovirus Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Oncolytic Adenovirus Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Oncolytic Adenovirus Market Size by Region (2020-2025) & (M USD)
Table 50. South America Oncolytic Adenovirus Sales by Country (2020-2025) & (K MT)
Table 51. South America Oncolytic Adenovirus Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Oncolytic Adenovirus Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Oncolytic Adenovirus Market Size by Region (2020-2025) & (M USD)
Table 54. Global Oncolytic Adenovirus Production (K MT) by Region(2020-2025)
Table 55. Global Oncolytic Adenovirus Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Oncolytic Adenovirus Revenue Market Share by Region (2020-2025)
Table 57. Global Oncolytic Adenovirus Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Oncolytic Adenovirus Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Oncolytic Adenovirus Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Oncolytic Adenovirus Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Oncolytic Adenovirus Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Merck Basic Information
Table 63. Merck Oncolytic Adenovirus Product Overview
Table 64. Merck Oncolytic Adenovirus Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Merck Business Overview
Table 66. Merck SWOT Analysis
Table 67. Merck Recent Developments
Table 68. Roche Basic Information
Table 69. Roche Oncolytic Adenovirus Product Overview
Table 70. Roche Oncolytic Adenovirus Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Roche Business Overview
Table 72. Roche SWOT Analysis
Table 73. Roche Recent Developments
Table 74. Transgene Basic Information
Table 75. Transgene Oncolytic Adenovirus Product Overview
Table 76. Transgene Oncolytic Adenovirus Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Transgene Business Overview
Table 78. Transgene SWOT Analysis
Table 79. Transgene Recent Developments
Table 80. Agenus Basic Information
Table 81. Agenus Oncolytic Adenovirus Product Overview
Table 82. Agenus Oncolytic Adenovirus Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Agenus Business Overview
Table 84. Agenus Recent Developments
Table 85. Oncorus Basic Information
Table 86. Oncorus Oncolytic Adenovirus Product Overview
Table 87. Oncorus Oncolytic Adenovirus Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Oncorus Business Overview
Table 89. Oncorus Recent Developments
Table 90. Viralytics Basic Information
Table 91. Viralytics Oncolytic Adenovirus Product Overview
Table 92. Viralytics Oncolytic Adenovirus Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Viralytics Business Overview
Table 94. Viralytics Recent Developments
Table 95. Amgen Basic Information
Table 96. Amgen Oncolytic Adenovirus Product Overview
Table 97. Amgen Oncolytic Adenovirus Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Amgen Business Overview
Table 99. Amgen Recent Developments
Table 100. Targovax Basic Information
Table 101. Targovax Oncolytic Adenovirus Product Overview
Table 102. Targovax Oncolytic Adenovirus Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Targovax Business Overview
Table 104. Targovax Recent Developments
Table 105. Sorrento Therapeutics Basic Information
Table 106. Sorrento Therapeutics Oncolytic Adenovirus Product Overview
Table 107. Sorrento Therapeutics Oncolytic Adenovirus Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Sorrento Therapeutics Business Overview
Table 109. Sorrento Therapeutics Recent Developments
Table 110. Shanghai Pharma Sunway Biotech Basic Information
Table 111. Shanghai Pharma Sunway Biotech Oncolytic Adenovirus Product Overview
Table 112. Shanghai Pharma Sunway Biotech Oncolytic Adenovirus Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Shanghai Pharma Sunway Biotech Business Overview
Table 114. Shanghai Pharma Sunway Biotech Recent Developments
Table 115. Jiangsu Hengrui Pharmaceuticals Basic Information
Table 116. Jiangsu Hengrui Pharmaceuticals Oncolytic Adenovirus Product Overview
Table 117. Jiangsu Hengrui Pharmaceuticals Oncolytic Adenovirus Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Jiangsu Hengrui Pharmaceuticals Business Overview
Table 119. Jiangsu Hengrui Pharmaceuticals Recent Developments
Table 120. Fosun Pharma Basic Information
Table 121. Fosun Pharma Oncolytic Adenovirus Product Overview
Table 122. Fosun Pharma Oncolytic Adenovirus Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Fosun Pharma Business Overview
Table 124. Fosun Pharma Recent Developments
Table 125. BeiGene Basic Information
Table 126. BeiGene Oncolytic Adenovirus Product Overview
Table 127. BeiGene Oncolytic Adenovirus Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. BeiGene Business Overview
Table 129. BeiGene Recent Developments
Table 130. Junshi Biosciences Basic Information
Table 131. Junshi Biosciences Oncolytic Adenovirus Product Overview
Table 132. Junshi Biosciences Oncolytic Adenovirus Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. Junshi Biosciences Business Overview
Table 134. Junshi Biosciences Recent Developments
Table 135. Chengdu Kanghua Biological Products Basic Information
Table 136. Chengdu Kanghua Biological Products Oncolytic Adenovirus Product Overview
Table 137. Chengdu Kanghua Biological Products Oncolytic Adenovirus Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 138. Chengdu Kanghua Biological Products Business Overview
Table 139. Chengdu Kanghua Biological Products Recent Developments
Table 140. 3SBio Basic Information
Table 141. 3SBio Oncolytic Adenovirus Product Overview
Table 142. 3SBio Oncolytic Adenovirus Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 143. 3SBio Business Overview
Table 144. 3SBio Recent Developments
Table 145. Changchun High and New Technology Industries Basic Information
Table 146. Changchun High and New Technology Industries Oncolytic Adenovirus Product Overview
Table 147. Changchun High and New Technology Industries Oncolytic Adenovirus Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 148. Changchun High and New Technology Industries Business Overview
Table 149. Changchun High and New Technology Industries Recent Developments
Table 150. Global Oncolytic Adenovirus Sales Forecast by Region (2026-2035) & (K MT)
Table 151. Global Oncolytic Adenovirus Market Size Forecast by Region (2026-2035) & (M USD)
Table 152. North America Oncolytic Adenovirus Sales Forecast by Country (2026-2035) & (K MT)
Table 153. North America Oncolytic Adenovirus Market Size Forecast by Country (2026-2035) & (M USD)
Table 154. Europe Oncolytic Adenovirus Sales Forecast by Country (2026-2035) & (K MT)
Table 155. Europe Oncolytic Adenovirus Market Size Forecast by Country (2026-2035) & (M USD)
Table 156. Asia Pacific Oncolytic Adenovirus Sales Forecast by Region (2026-2035) & (K MT)
Table 157. Asia Pacific Oncolytic Adenovirus Market Size Forecast by Region (2026-2035) & (M USD)
Table 158. South America Oncolytic Adenovirus Sales Forecast by Country (2026-2035) & (K MT)
Table 159. South America Oncolytic Adenovirus Market Size Forecast by Country (2026-2035) & (M USD)
Table 160. Middle East and Africa Oncolytic Adenovirus Sales Forecast by Country (2026-2035) & (Units)
Table 161. Middle East and Africa Oncolytic Adenovirus Market Size Forecast by Country (2026-2035) & (M USD)
Table 162. Global Oncolytic Adenovirus Sales Forecast by Type (2026-2035) & (K MT)
Table 163. Global Oncolytic Adenovirus Market Size Forecast by Type (2026-2035) & (M USD)
Table 164. Global Oncolytic Adenovirus Price Forecast by Type (2026-2035) & (USD/KG)
Table 165. Global Oncolytic Adenovirus Sales (K MT) Forecast by Application (2026-2035)
Table 166. Global Oncolytic Adenovirus Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Oncolytic Adenovirus
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Oncolytic Adenovirus Market Size (M USD), 2025-2035
Figure 5. Global Oncolytic Adenovirus Market Size (M USD) (2020-2035)
Figure 6. Global Oncolytic Adenovirus Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Oncolytic Adenovirus Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Oncolytic Adenovirus Product Life Cycle
Figure 13. Oncolytic Adenovirus Sales Share by Manufacturers in 2025
Figure 14. Global Oncolytic Adenovirus Revenue Share by Manufacturers in 2025
Figure 15. Oncolytic Adenovirus Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Oncolytic Adenovirus Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Oncolytic Adenovirus Revenue in 2025
Figure 18. Industry Chain Map of Oncolytic Adenovirus
Figure 19. Global Oncolytic Adenovirus Market PEST Analysis
Figure 20. Global Oncolytic Adenovirus Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Oncolytic Adenovirus Market Share by Type
Figure 27. Sales Market Share of Oncolytic Adenovirus by Type (2020-2025)
Figure 28. Sales Market Share of Oncolytic Adenovirus by Type in 2025
Figure 29. Market Share of Oncolytic Adenovirus by Type (2020-2025)
Figure 30. Market Share of Oncolytic Adenovirus by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Oncolytic Adenovirus Market Share by Application
Figure 33. Global Oncolytic Adenovirus Sales Market Share by Application (2020-2025)
Figure 34. Global Oncolytic Adenovirus Sales Market Share by Application in 2025
Figure 35. Global Oncolytic Adenovirus Market Share by Application (2020-2025)
Figure 36. Global Oncolytic Adenovirus Market Share by Application in 2025
Figure 37. Global Oncolytic Adenovirus Sales Growth Rate by Application (2020-2025)
Figure 38. Global Oncolytic Adenovirus Sales Market Share by Region (2020-2025)
Figure 39. Global Oncolytic Adenovirus Market Size by Region (2020-2025)
Figure 40. North America Oncolytic Adenovirus Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Oncolytic Adenovirus Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Oncolytic Adenovirus Sales Market Share by Country in 2024
Figure 43. North America Oncolytic Adenovirus Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Oncolytic Adenovirus Market Size by Country in 2024
Figure 45. U.S. Oncolytic Adenovirus Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Oncolytic Adenovirus Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Oncolytic Adenovirus Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Oncolytic Adenovirus Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Oncolytic Adenovirus Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Oncolytic Adenovirus Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Oncolytic Adenovirus Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Oncolytic Adenovirus Sales Market Share by Country in 2024
Figure 53. Europe Oncolytic Adenovirus Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Oncolytic Adenovirus Market Size by Country in 2024
Figure 55. Germany Oncolytic Adenovirus Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Oncolytic Adenovirus Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Oncolytic Adenovirus Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Oncolytic Adenovirus Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Oncolytic Adenovirus Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Oncolytic Adenovirus Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Oncolytic Adenovirus Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Oncolytic Adenovirus Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Oncolytic Adenovirus Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Oncolytic Adenovirus Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Oncolytic Adenovirus Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Oncolytic Adenovirus Sales Market Share by Region in 2024
Figure 67. Asia Pacific Oncolytic Adenovirus Market Size by Region in 2024
Figure 68. China Oncolytic Adenovirus Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Oncolytic Adenovirus Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Oncolytic Adenovirus Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Oncolytic Adenovirus Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Oncolytic Adenovirus Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Oncolytic Adenovirus Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Oncolytic Adenovirus Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Oncolytic Adenovirus Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Oncolytic Adenovirus Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Oncolytic Adenovirus Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Oncolytic Adenovirus Sales and Growth Rate (K MT)
Figure 79. South America Oncolytic Adenovirus Sales Market Share by Country in 2024
Figure 80. South America Oncolytic Adenovirus Market Size and Growth Rate (M USD)
Figure 81. South America Oncolytic Adenovirus Market Size by Country in 2024
Figure 82. Brazil Oncolytic Adenovirus Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Oncolytic Adenovirus Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Oncolytic Adenovirus Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Oncolytic Adenovirus Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Oncolytic Adenovirus Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Oncolytic Adenovirus Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Oncolytic Adenovirus Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Oncolytic Adenovirus Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Oncolytic Adenovirus Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Oncolytic Adenovirus Market Size by Region in 2024
Figure 92. Saudi Arabia Oncolytic Adenovirus Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Oncolytic Adenovirus Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Oncolytic Adenovirus Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Oncolytic Adenovirus Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Oncolytic Adenovirus Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Oncolytic Adenovirus Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Oncolytic Adenovirus Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Oncolytic Adenovirus Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Oncolytic Adenovirus Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Oncolytic Adenovirus Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Oncolytic Adenovirus Production Market Share by Region (2020-2025)
Figure 103. North America Oncolytic Adenovirus Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Oncolytic Adenovirus Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Oncolytic Adenovirus Production (K MT) Growth Rate (2020-2025)
Figure 106. China Oncolytic Adenovirus Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Oncolytic Adenovirus Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Oncolytic Adenovirus Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Oncolytic Adenovirus Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Oncolytic Adenovirus Market Share Forecast by Type (2026-2035)
Figure 111. Global Oncolytic Adenovirus Sales Forecast by Application (2026-2035)
Figure 112. Global Oncolytic Adenovirus Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Oncolytic Adenovirus
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Oncolytic Adenovirus Market Size (M USD), 2025-2035
Figure 5. Global Oncolytic Adenovirus Market Size (M USD) (2020-2035)
Figure 6. Global Oncolytic Adenovirus Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Oncolytic Adenovirus Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Oncolytic Adenovirus Product Life Cycle
Figure 13. Oncolytic Adenovirus Sales Share by Manufacturers in 2025
Figure 14. Global Oncolytic Adenovirus Revenue Share by Manufacturers in 2025
Figure 15. Oncolytic Adenovirus Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Oncolytic Adenovirus Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Oncolytic Adenovirus Revenue in 2025
Figure 18. Industry Chain Map of Oncolytic Adenovirus
Figure 19. Global Oncolytic Adenovirus Market PEST Analysis
Figure 20. Global Oncolytic Adenovirus Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Oncolytic Adenovirus Market Share by Type
Figure 27. Sales Market Share of Oncolytic Adenovirus by Type (2020-2025)
Figure 28. Sales Market Share of Oncolytic Adenovirus by Type in 2025
Figure 29. Market Share of Oncolytic Adenovirus by Type (2020-2025)
Figure 30. Market Share of Oncolytic Adenovirus by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Oncolytic Adenovirus Market Share by Application
Figure 33. Global Oncolytic Adenovirus Sales Market Share by Application (2020-2025)
Figure 34. Global Oncolytic Adenovirus Sales Market Share by Application in 2025
Figure 35. Global Oncolytic Adenovirus Market Share by Application (2020-2025)
Figure 36. Global Oncolytic Adenovirus Market Share by Application in 2025
Figure 37. Global Oncolytic Adenovirus Sales Growth Rate by Application (2020-2025)
Figure 38. Global Oncolytic Adenovirus Sales Market Share by Region (2020-2025)
Figure 39. Global Oncolytic Adenovirus Market Size by Region (2020-2025)
Figure 40. North America Oncolytic Adenovirus Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Oncolytic Adenovirus Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Oncolytic Adenovirus Sales Market Share by Country in 2024
Figure 43. North America Oncolytic Adenovirus Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Oncolytic Adenovirus Market Size by Country in 2024
Figure 45. U.S. Oncolytic Adenovirus Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Oncolytic Adenovirus Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Oncolytic Adenovirus Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Oncolytic Adenovirus Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Oncolytic Adenovirus Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Oncolytic Adenovirus Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Oncolytic Adenovirus Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Oncolytic Adenovirus Sales Market Share by Country in 2024
Figure 53. Europe Oncolytic Adenovirus Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Oncolytic Adenovirus Market Size by Country in 2024
Figure 55. Germany Oncolytic Adenovirus Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Oncolytic Adenovirus Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Oncolytic Adenovirus Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Oncolytic Adenovirus Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Oncolytic Adenovirus Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Oncolytic Adenovirus Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Oncolytic Adenovirus Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Oncolytic Adenovirus Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Oncolytic Adenovirus Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Oncolytic Adenovirus Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Oncolytic Adenovirus Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Oncolytic Adenovirus Sales Market Share by Region in 2024
Figure 67. Asia Pacific Oncolytic Adenovirus Market Size by Region in 2024
Figure 68. China Oncolytic Adenovirus Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Oncolytic Adenovirus Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Oncolytic Adenovirus Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Oncolytic Adenovirus Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Oncolytic Adenovirus Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Oncolytic Adenovirus Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Oncolytic Adenovirus Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Oncolytic Adenovirus Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Oncolytic Adenovirus Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Oncolytic Adenovirus Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Oncolytic Adenovirus Sales and Growth Rate (K MT)
Figure 79. South America Oncolytic Adenovirus Sales Market Share by Country in 2024
Figure 80. South America Oncolytic Adenovirus Market Size and Growth Rate (M USD)
Figure 81. South America Oncolytic Adenovirus Market Size by Country in 2024
Figure 82. Brazil Oncolytic Adenovirus Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Oncolytic Adenovirus Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Oncolytic Adenovirus Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Oncolytic Adenovirus Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Oncolytic Adenovirus Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Oncolytic Adenovirus Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Oncolytic Adenovirus Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Oncolytic Adenovirus Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Oncolytic Adenovirus Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Oncolytic Adenovirus Market Size by Region in 2024
Figure 92. Saudi Arabia Oncolytic Adenovirus Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Oncolytic Adenovirus Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Oncolytic Adenovirus Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Oncolytic Adenovirus Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Oncolytic Adenovirus Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Oncolytic Adenovirus Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Oncolytic Adenovirus Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Oncolytic Adenovirus Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Oncolytic Adenovirus Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Oncolytic Adenovirus Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Oncolytic Adenovirus Production Market Share by Region (2020-2025)
Figure 103. North America Oncolytic Adenovirus Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Oncolytic Adenovirus Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Oncolytic Adenovirus Production (K MT) Growth Rate (2020-2025)
Figure 106. China Oncolytic Adenovirus Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Oncolytic Adenovirus Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Oncolytic Adenovirus Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Oncolytic Adenovirus Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Oncolytic Adenovirus Market Share Forecast by Type (2026-2035)
Figure 111. Global Oncolytic Adenovirus Sales Forecast by Application (2026-2035)
Figure 112. Global Oncolytic Adenovirus Market Share Forecast by Application (2026-2035)
